Search Results - "Kranias, G"

Refine Results
  1. 1

    Modulation of Cardiac Contractility by the Phopholamban/SERCA2a Regulatome by Kranias, Evangelia G, Hajjar, Roger J

    Published in Circulation research (08-06-2012)
    “…Heart disease remains the leading cause of death and disability in the Western world. Current therapies aim at treating the symptoms rather than the…”
    Get full text
    Journal Article
  2. 2

    Phospholamban interactome in cardiac contractility and survival: A new vision of an old friend by Haghighi, Kobra, Bidwell, Philip, Kranias, Evangelia G

    “…Abstract Depressed sarcoplasmic reticulum (SR) calcium cycling, reflecting impaired SR Ca-transport and Ca-release, is a key and universal characteristic of…”
    Get full text
    Journal Article
  3. 3

    Hsp20 functions as a novel cardiokine in promoting angiogenesis via activation of VEGFR2 by Zhang, Xiaowei, Wang, Xiaohong, Zhu, Hongyan, Kranias, Evangelia G, Tang, Yaoliang, Peng, Tianqing, Chang, Jiang, Fan, Guo-Chang

    Published in PloS one (12-03-2012)
    “…Heat shock proteins (Hsps) are well appreciated as intrinsic protectors of cardiomyocytes against numerous stresses. Recent studies have indicated that Hsp20…”
    Get full text
    Journal Article
  4. 4

    Phospholamban: a crucial regulator of cardiac contractility by MacLennan, David H, Kranias, Evangelia G

    Published in Nature reviews. Molecular cell biology (01-07-2003)
    “…Heart failure is a major cause of death and disability. Impairments in blood circulation that accompany heart failure can be traced, in part, to alterations in…”
    Get full text
    Journal Article
  5. 5

    Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN) by Doevendans, Pieter A, Glijnis, Pieter C, Kranias, Evangelia G

    Published in Circulation research (13-09-2019)
    “…The deletion of Arginine 14 of the phosholamban gene (PLN p.R14del) is associated with the pathogenesis of an inherited form of cardiomyopathy with prominent…”
    Get full text
    Journal Article
  6. 6

    The role of CaMKII regulation of phospholamban activity in heart disease by Mattiazzi, Alicia, Kranias, Evangelia G

    Published in Frontiers in pharmacology (2014)
    “…Phospholamban (PLN) is a phosphoprotein in cardiac sarcoplasmic reticulum (SR) that is a reversible regulator of the Ca(2) (+)-ATPase (SERCA2a) activity and…”
    Get full text
    Journal Article
  7. 7

    Aberrant PLN-R14del Protein Interactions Intensify SERCA2a Inhibition, Driving Impaired Ca2+ Handling and Arrhythmogenesis by Vafiadaki, Elizabeth, Haghighi, Kobra, Arvanitis, Demetrios A., Kranias, Evangelia G., Sanoudou, Despina

    “…Phospholamban (PLN), a key modulator of Ca2+-homeostasis, inhibits sarcoplasmic reticulum (SR) calcium-ATPase (SERCA2a) and regulates cardiac contractility…”
    Get full text
    Journal Article
  8. 8

    Small heat shock protein 20 (HspB6) in cardiac hypertrophy and failure by Fan, Guo-Chang, Kranias, Evangelia G

    “…Abstract Hsp20, referred to as HspB6, is constitutively expressed in various tissues. Specifically, HspB6 is most highly expressed in different types of muscle…”
    Get full text
    Journal Article
  9. 9

    HAX-1 regulates cyclophilin-D levels and mitochondria permeability transition pore in the heart by Lam, Chi Keung, Zhao, Wen, Liu, Guan-Sheng, Cai, Wen-Feng, Gardner, George, Adly, George, Kranias, Evangelia G.

    “…The major underpinning of massive cell death associated with myocardial infarction involves opening of the mitochondrial permeability transition pore (mPTP),…”
    Get full text
    Journal Article
  10. 10

    Mitigation of muscular dystrophy in mice by SERCA overexpression in skeletal muscle by Goonasekera, Sanjeewa A, Lam, Chi K, Millay, Douglas P, Sargent, Michelle A, Hajjar, Roger J, Kranias, Evangelia G, Molkentin, Jeffery D

    Published in The Journal of clinical investigation (01-03-2011)
    “…Muscular dystrophies (MDs) comprise a group of degenerative muscle disorders characterized by progressive muscle wasting and often premature death. The primary…”
    Get full text
    Journal Article
  11. 11

    A novel role for phospholamban in the thalamic reticular nucleus by Klocke, Benjamin, Britzolaki, Aikaterini, Saurine, Joseph, Ott, Hayden, Krone, Kylie, Bahamonde, Kiara, Thelen, Connor, Tzimas, Christos, Sanoudou, Despina, Kranias, Evangelia G., Pitychoutis, Pothitos M.

    Published in Scientific reports (16-03-2024)
    “…The thalamic reticular nucleus (TRN) is a brain region that influences vital neurobehavioral processes, including executive functioning and the generation of…”
    Get full text
    Journal Article
  12. 12

    Myofilament Alterations Associated with Human R14del-Phospholamban Cardiomyopathy by Kumar, Mohit, Haghighi, Kobra, Koch, Sheryl, Rubinstein, Jack, Stillitano, Francesca, Hajjar, Roger J, Kranias, Evangelia G, Sadayappan, Sakthivel

    “…Phospholamban ( ) is a major regulator of cardiac contractility, and human mutations in this gene give rise to inherited cardiomyopathies. The deletion of…”
    Get full text
    Journal Article
  13. 13

    The Cardioprotective PKA-Mediated Hsp20 Phosphorylation Modulates Protein Associations Regulating Cytoskeletal Dynamics by Vafiadaki, Elizabeth, Arvanitis, Demetrios A, Eliopoulos, Aristides G, Kranias, Evangelia G, Sanoudou, Despina

    “…The cytoskeleton has a primary role in cardiomyocyte function, including the response to mechanical stimuli and injury. The small heat shock protein 20 (Hsp20)…”
    Get full text
    Journal Article
  14. 14

    Hsp20‐Engineered Mesenchymal Stem Cells Are Resistant to Oxidative Stress via Enhanced Activation of Akt and Increased Secretion of Growth Factors by Wang, Xiaohong, Zhao, Tiemin, Huang, Wei, Wang, Tao, Qian, Jiang, Xu, Meifeng, Kranias, Evangelia G., Wang, Yigang, Fan, Guo‐Chang

    Published in Stem cells (Dayton, Ohio) (01-12-2009)
    “…Although heat‐shock preconditioning has been shown to promote cell survival under oxidative stress, the nature of heat‐shock response from different cells is…”
    Get full text
    Journal Article
  15. 15

    Dilated Cardiomyopathy and Heart Failure Caused by a Mutation in Phospholamban by Schmitt, Joachim P., Kamisago, Mitsuhiro, Asahi, Michio, Li, Guo Hua, Ahmad, Ferhaan, Mende, Ulrike, Kranias, Evangelia G., MacLennan, David H., Seidman, J. G., Seidman, Christine E.

    “…Molecular etiologies of heart failure, an emerging cardiovascular epidemic affecting 4.7 million Americans and costing 17.8 billion health-care dollars…”
    Get full text
    Journal Article
  16. 16

    Probenecid treatment improves outcomes in a novel mouse model of peripartum cardiomyopathy by Onusko, Evan, McDermott, Michael R, Robbins, Nathan, Liu, Guansheng, Kranias, Evangelia G, Rubinstein, Jack, Koch, Sheryl E

    Published in PloS one (27-03-2020)
    “…Probenecid has been used for decades in the treatment of gout but recently has also been found to improve outcomes in patients with heart failure via…”
    Get full text
    Journal Article
  17. 17

    Role of protein phosphatase-1 inhibitor-1 in cardiac physiology and pathophysiology by Nicolaou, Persoulla, Hajjar, Roger J, Kranias, Evangelia G

    “…Abstract The type 1 protein phosphatase (PP1) is a critical negative regulator of Ca2+ cycling and contractility in the cardiomyocyte. In particular, it…”
    Get full text
    Journal Article
  18. 18

    CaMKII inhibition protects against necrosis and apoptosis in irreversible ischemia-reperfusion injury by Vila-Petroff, Martin, Salas, Margarita A, Said, Matilde, Valverde, Carlos A, Sapia, Luciana, Portiansky, Enrique, Hajjar, Roger J, Kranias, Evangelia G, Mundiña-Weilenmann, Cecilia, Mattiazzi, Alicia

    Published in Cardiovascular research (01-03-2007)
    “…Ca(2+)/calmodulin-dependent protein kinase II (CaMKII) has been implicated in the regulation of cardiac excitation-contraction coupling (ECC) as well as in…”
    Get full text
    Journal Article
  19. 19
  20. 20